Provided by Tiger Fintech (Singapore) Pte. Ltd.

IQVIA

162.61
+5.023.19%
Post-market: 162.610.00000.00%17:05 EDT
Volume:1.50M
Turnover:243.76M
Market Cap:28.13B
PE:22.14
High:167.32
Open:157.31
Low:156.01
Close:157.59
Loading ...

IQVIA Holdings Inc. to Announce Second-Quarter 2025 Results

Reuters
·
Yesterday

Iqvia price target lowered to $180 from $190 at BofA

TIPRANKS
·
25 Jun

Inside Nvidia’s Investment Blueprint: Mapping the Next Empire of AI, Automation, and Infrastructure

TradingKey
·
25 Jun

IQVIA Holdings (IQV) Gets a Hold from Barclays

TIPRANKS
·
25 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Jun

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating

MT Newswires Live
·
17 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 Jun

IQVIA Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
14 Jun

IQVIA Holdings Inc. Partners with NVIDIA to Enhance AI in Life Sciences and Healthcare

Reuters
·
11 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
10 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
07 Jun

IQVIA Holdings Issues $2 Billion in Senior Notes

TIPRANKS
·
05 Jun

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
04 Jun

IQVIA Holdings Inc. Announces $2 Billion Senior Notes Offering

Reuters
·
02 Jun

IQVIA Announces Offering of Senior Notes

THOMSON REUTERS
·
02 Jun

IQVIA Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
29 May

IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 May

BRIEF-Rein Therapeutics Announces First Patient Dosed In Renew Phase 2 Trial Of Lti-03 In Patients With Ipf

Reuters
·
27 May

Rein Therapeutics Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients With Ipf

THOMSON REUTERS
·
27 May

Rein Therapeutics Inc: Topline Interim Data From Renew Is Expected in First Half of 2026

THOMSON REUTERS
·
27 May